PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Brenntag Pharma and dsm‑firmenich enter long‑term global partnership for GMP grade vitamins under new Biopharma co‑brand BYPHAR powered by Biond™

  • The strategic partnership expands Brenntag’s Biopharma ingredients portfolio BYPHAR
  • BYPHAR powered by Biond™ will be presented publicly at CPHI, Milano, with an After Dark Event on Wednesday, October 7th, 5:30pm at the Brenntag booth (1A26)
  • This agreement is a milestone in the long-standing partnership with dsm-firmenich, spanning more than 30 years

Brenntag, the global market leader in chemicals and ingredients distribution, and dsm‑firmenich today announced the signing of a global distribution agreement combined with a long‑term strategic partnership. The collaboration aims to strengthen the worldwide availability of high‑purity, GMP‑grade vitamins. The partnership will operate under the new co‑brand BYPHAR powered by Biond™, dsm-firmenich’s portfolio of high-purity vitamins specifically designed for cell culture media and biologics manufacturing.

The agreement grants Brenntag exclusive distribution rights for dsm‑firmenich’s Biopharma‑grade vitamin portfolio – Biond™ – across all major biopharma regions: North America, LATAM, Europe, MEA, and APAC.

Eight BYPHAR powered by Biond™ products in multiple pack sizes will be available:

  • BiondTM Niacinamide Ph Excel (B3)
  • BiondTM Folic Acid Ph Excel (B9)
  • BiondTM Cyanocobalamin Ph Excel (B12)
  • BiondTM D-Panthenol Ph Excel (B5)
  • BiondTM Thiamine Hydrochloride Ph Excel (B1)
  • BiondTM Riboflavin 5′-Phosphate Ph Excel (B2)
  • BiondTM Pyridoxine Hydrochloride Ph Excel (B6)
  • BiondTM D-Biotin Ph Excel (B7)

The vitamins are designed for use in cell culture media, feed media, and upstream bioprocessing, supporting the production of biologics, vaccines, and cell therapies as critical ingredients for healthy cell growth. Key product attributes include:

  • High‑purity GMP‑grade quality with multi‑compendial compliance
  • Pack size flexibility from R&D to commercial scale
  • Reliable global supply chain and technical support

These features address core industry requirements like consistent cell performance, process robustness, and scalable manufacturing reliability.

“With this partnership, we significantly expand our global biopharma portfolio and reinforce our ability to support customers who depend on stable, quality‑assured raw materials,” said Gust Desmedt, Global President Pharma at Brenntag. “BYPHAR powered by Biond™ reflects a shared commitment to quality, reliability, and secure supply for critical upstream processes.”

“Biond™ was created to address the evolving needs of biologics manufacturers, who increasingly require not only high-purity raw materials, but also assurance around quality, reliability, and technical expertise. Our partnership with Brenntag Pharma combines complementary strengths to deliver a dedicated offering for biopharmaceutical applications under the BYPHAR brand, helping customers move forward with greater confidence and control,” said Fernanda Onofre, Director Global Marketing and Business Development, Pharma Biologics Solutions, Health, Nutrition and Care at dsm-firmenich.

About dsm-firmenich:

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for people and the planet. dsm-firmenich is a Swiss company, listed on the Euronext Amsterdam and SIX Swiss Exchange, with operations in almost 60 countries and revenues of more than €9 billion for its Continuing Operations following the divestment of Animal Nutrition & Health. With a diverse, worldwide team of nearly 21,000 employees, we bring progress to life every day, everywhere, for billions of people.  www.dsm-firmenich.com Biond™ is a trademark of dsm-firmenich group.

About Brenntag:

Brenntag is the global market leader in chemicals and ingredients distribution. The company holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, Brenntag has more than 17,300 employees worldwide and operates a network of around 600 sites in more than 70 countries. In 2025, Brenntag generated sales of 15.2 billion EUR. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a diversified and broad portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions for a wide range of industries. Brenntag pursues an ambitious sustainability agenda and is committed to sustainable solutions in its own sector and the industries served. Brenntag shares have been listed at the Frankfurt Stock Exchange since 2010, in the DAX since September 2021. In addition, the Brenntag SE shares are listed in the DAX 30 ESG and DAX ESG Target. For more information, visit www.brenntag.com. 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026